Paul K. Wotton
2011
In 2011, Paul K. Wotton earned a total compensation of $1.2M as Chief Executive Officer at Antares Pharma, a 54% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $350,000 |
|---|---|
| Option Awards | $99,863 |
| Salary | $446,000 |
| Stock Awards | $262,517 |
| Other | $8,250 |
| Total | $1,166,630 |
Wotton received $446K in salary, accounting for 38% of the total pay in 2011.
Wotton also received $350K in non-equity incentive plan, $99.9K in option awards, $262.5K in stock awards and $8.3K in other compensation.
Rankings
In 2011, Paul K. Wotton's compensation ranked 5,093rd out of 10,747 executives tracked by ExecPay. In other words, Wotton earned more than 52.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,093 out of 10,747 | 53rd |
Division Manufacturing | 1,838 out of 3,960 | 54th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 260 out of 642 | 60th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 128 out of 356 | 64th |
Industry Surgical and Medical Instruments and Apparatus | 71 out of 216 | 67th |
Source: SEC filing on April 16, 2014.
Wotton's colleagues
We found three more compensation records of executives who worked with Paul K. Wotton at Antares Pharma in 2011.